• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2011 年至 2015 年中国医疗保健与高血压治疗结局的趋势和不平等。

Trends and Inequalities in the Health Care and Hypertension Outcomes in China, 2011 to 2015.

机构信息

The Nossal Institute for Global Health, The University of Melbourne, Melbourne 3010, Australia.

WHO Collaborating Centre on Implementation Research for Prevention & Control of NCDs, Melbourne 3010, Australia.

出版信息

Int J Environ Res Public Health. 2019 Nov 19;16(22):4578. doi: 10.3390/ijerph16224578.

DOI:10.3390/ijerph16224578
PMID:31752338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6888605/
Abstract

Hypertension is one of the most significant and common risk factors for cardiovascular disease, yet it remains poorly controlled in China. This study aims to examine trends and socioeconomic inequalities in the management of hypertension between 2011 and 2015 in China and to investigate the association between antihypertensive medication treatment and reduction of blood pressure, using nationally representative data. Concentration curve and concentration index were used to assess socioeconomic-related inequalities in hypertension care and health service utilisation. The fixed-effects analysis was performed to measure the impact of medication treatment on reduction of blood pressure among people with hypertension by using linear regression models. : Among hypertensive individuals, there were growing trends in the rates of awareness and treatment from 55.87% and 48.44% in 2011, to 68.31% in 2013 and 61.97% in 2015, respectively. The proportion of hypertension control was still below 30%. The fixed-effects models indicated that medication treatment was statistically significant and associated with the patients' systolic blood pressure (β: -13.483; 95% CI: -15.672, -11.293) and diastolic blood pressure (β: -5.367; 95% CI: -6.390, -4.344). China has made good progress in the hypertension diagnosis, medication treatment and coverage of health services over the last 10 years; however, pro-rich inequalities in hypertension care still exist, and there is considerable progress to be made in the prevention, treatment and effective control of hypertension.

摘要

高血压是心血管疾病最重要和最常见的危险因素之一,但在中国,高血压的控制仍然很差。本研究旨在考察 2011 年至 2015 年期间中国高血压管理的趋势和社会经济不平等,并利用全国代表性数据探讨降压药物治疗与血压降低之间的关系。使用集中曲线和集中指数评估高血压护理和卫生服务利用方面的社会经济相关不平等。使用线性回归模型,通过固定效应分析来衡量药物治疗对高血压患者血压降低的影响。在高血压患者中,知晓率和治疗率呈上升趋势,从 2011 年的 55.87%和 48.44%分别上升到 2013 年的 68.31%和 2015 年的 61.97%。高血压控制率仍低于 30%。固定效应模型表明,药物治疗与患者的收缩压(β:-13.483;95%CI:-15.672,-11.293)和舒张压(β:-5.367;95%CI:-6.390,-4.344)均有统计学意义。过去 10 年来,中国在高血压诊断、药物治疗和卫生服务覆盖方面取得了良好进展;然而,高血压护理方面仍然存在富裕程度不平等的问题,在高血压的预防、治疗和有效控制方面仍有很大的进步空间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/631d/6888605/7bf3de6b3a1e/ijerph-16-04578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/631d/6888605/c2619630df7a/ijerph-16-04578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/631d/6888605/7bf3de6b3a1e/ijerph-16-04578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/631d/6888605/c2619630df7a/ijerph-16-04578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/631d/6888605/7bf3de6b3a1e/ijerph-16-04578-g002.jpg

相似文献

1
Trends and Inequalities in the Health Care and Hypertension Outcomes in China, 2011 to 2015.2011 年至 2015 年中国医疗保健与高血压治疗结局的趋势和不平等。
Int J Environ Res Public Health. 2019 Nov 19;16(22):4578. doi: 10.3390/ijerph16224578.
2
Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).中国高血压的患病率、知晓率、治疗率和控制率:一项基于人群筛查研究的 170 万成年人数据(中国高血压调查)。
Lancet. 2017 Dec 9;390(10112):2549-2558. doi: 10.1016/S0140-6736(17)32478-9. Epub 2017 Nov 5.
3
Analysis on associated factors of uncontrolled hypertension among elderly hypertensive patients in Southern China: a community-based, cross-sectional survey.中国南方老年高血压患者血压控制不佳的相关因素分析:一项基于社区的横断面调查
BMC Public Health. 2014 Sep 2;14:903. doi: 10.1186/1471-2458-14-903.
4
Socioeconomic differences in prevalence, awareness, control and self-management of hypertension among four minority ethnic groups, Na Xi, Li Shu, Dai and Jing Po, in rural southwest China.中国西南部农村纳西族、僳僳族、傣族和景颇族四个少数民族高血压患病率、知晓率、控制率及自我管理方面的社会经济差异。
J Hum Hypertens. 2017 Jun;31(6):388-394. doi: 10.1038/jhh.2016.87. Epub 2017 Jan 5.
5
The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults.44 个低收入和中等收入国家的高血压护理状况:来自 110 万成年人的全国代表性个体水平数据的横断面研究。
Lancet. 2019 Aug 24;394(10199):652-662. doi: 10.1016/S0140-6736(19)30955-9. Epub 2019 Jul 18.
6
Hypertension awareness, treatment, and control and their association with healthcare access in the middle-aged and older Indian population: A nationwide cohort study.中年和老年印度人群的高血压知晓率、治疗率和控制率及其与医疗保健可及性的关系:一项全国性队列研究。
PLoS Med. 2022 Jan 4;19(1):e1003855. doi: 10.1371/journal.pmed.1003855. eCollection 2022 Jan.
7
Socioeconomic inequalities in the utilisation of hypertension and type 2 diabetes management services in Indonesia.印度尼西亚高血压和 2 型糖尿病管理服务利用中的社会经济不平等。
Trop Med Int Health. 2019 Nov;24(11):1301-1310. doi: 10.1111/tmi.13303. Epub 2019 Sep 15.
8
Gender differences in hypertension awareness, antihypertensive use and blood pressure control in Nepalese adults: findings from a nationwide cross-sectional survey.尼泊尔成年人高血压知晓率、降压药物使用率和血压控制的性别差异:全国性横断面调查研究结果。
J Biosoc Sci. 2020 May;52(3):412-438. doi: 10.1017/S0021932019000531. Epub 2019 Aug 30.
9
Socioeconomic inequalities in the prevalence of chronic diseases and preventive care among adults aged 45 and older in Shaanxi Province, China.中国陕西省 45 岁及以上成年人中慢性疾病和预防保健的社会经济不平等现象。
BMC Public Health. 2019 Nov 6;19(1):1460. doi: 10.1186/s12889-019-7835-5.
10
Prevalence, awareness, treatment, and control of hypertension among residents in Guangdong Province, China, 2004 to 2007.2004年至2007年中国广东省居民高血压的患病率、知晓率、治疗率和控制率
Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):217-22. doi: 10.1161/CIRCOUTCOMES.111.000062. Epub 2013 Mar 12.

引用本文的文献

1
Comparison of Health Care Utilization in Different Usual Sources of Care Among Older People With Cardiovascular Disease in China: Evidence From the Study on Global Ageing and Adult Health.中国心血管疾病老年人不同常规照护来源的医疗利用比较:来自全球老龄化和成人健康研究的证据。
Int J Public Health. 2024 Jan 3;68:1606103. doi: 10.3389/ijph.2023.1606103. eCollection 2023.
2
Explanation of Socio-economic Inequality in Medicine Use: A Cross-sectional Analysis from Iran.医疗使用中的社会经济不平等现象解析:来自伊朗的横断面分析
Iran J Pharm Res. 2022 Dec 31;21(1):e129431. doi: 10.5812/ijpr-129431. eCollection 2022 Dec.
3

本文引用的文献

1
Temporal Trends and Geographic Disparity in Hypertension Care in China.中国高血压护理的时间趋势与地理差异
J Epidemiol. 2020 Aug 5;30(8):354-361. doi: 10.2188/jea.JE20190029. Epub 2019 Jul 20.
2
Hypertension in China: Time to Transition From Knowing the Problem to Implementing the Solution.中国的高血压:是时候从认识问题转向实施解决方案了。
Circulation. 2018 May 29;137(22):2357-2359. doi: 10.1161/CIRCULATIONAHA.118.034028.
3
Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015.中国高血压现状:2012-2015 年中国高血压调查结果。
Systematic literature review and meta-analysis of cardiovascular risk factor management in selected Asian countries.
系统文献回顾和选定亚洲国家心血管危险因素管理的荟萃分析。
J Comp Eff Res. 2023 Apr;12(4):e220085. doi: 10.57264/cer-2022-0085. Epub 2023 Mar 2.
4
Factors associated with health care utilization and catastrophic health expenditure among cancer patients in China: Evidence from the China health and retirement longitudinal study.中国癌症患者的医疗保健利用和灾难性卫生支出相关因素:来自中国健康与养老追踪调查的证据。
Front Public Health. 2022 Nov 10;10:943271. doi: 10.3389/fpubh.2022.943271. eCollection 2022.
5
Urban-Rural Differences: The Impact of Social Support on the Use of Multiple Healthcare Services for Older People.城乡差异:社会支持对老年人使用多种医疗保健服务的影响。
Front Public Health. 2022 Apr 14;10:851616. doi: 10.3389/fpubh.2022.851616. eCollection 2022.
6
Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China.原研药与仿制药治疗高血压的临床疗效及医疗成本:基于中国鄞州人群的研究
Front Pharmacol. 2022 Feb 22;13:757398. doi: 10.3389/fphar.2022.757398. eCollection 2022.
7
Socio-Economic and Rural-Urban Differences in Healthcare and Catastrophic Health Expenditure Among Cancer Patients in China: Analysis of the China Health and Retirement Longitudinal Study.中国癌症患者的医疗保健和灾难性卫生支出的社会经济和城乡差异:基于中国健康与养老追踪调查的分析。
Front Public Health. 2022 Jan 11;9:779285. doi: 10.3389/fpubh.2021.779285. eCollection 2021.
8
Changes of Multisectoral Collaboration and Service Delivery in Hypertension Prevention and Control before and after the 2009 New Healthcare Reform in China: An Interrupted Time-Series Study.中国 2009 年新医改前后高血压防控多部门协作和服务提供的变化:一项中断时间序列研究。
J Healthc Eng. 2021 Sep 20;2021:8976625. doi: 10.1155/2021/8976625. eCollection 2021.
9
Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19.与2019冠状病毒病相关的心血管和肾脏危险因素及并发症
CJC Open. 2021 Oct;3(10):1257-1272. doi: 10.1016/j.cjco.2021.05.020. Epub 2021 Jun 16.
10
The changes in socioeconomic inequalities and inequities in health services utilization among patients with hypertension in Pearl River Delta of China, 2015 and 2019.2015年和2019年中国珠江三角洲高血压患者健康服务利用方面社会经济不平等和不公平现象的变化。
BMC Public Health. 2021 May 12;21(1):903. doi: 10.1186/s12889-021-10879-6.
Circulation. 2018 May 29;137(22):2344-2356. doi: 10.1161/CIRCULATIONAHA.117.032380. Epub 2018 Feb 15.
4
Health system strengthening and hypertension management in China.中国的卫生系统加强与高血压管理
Glob Health Res Policy. 2016 Sep 21;1:13. doi: 10.1186/s41256-016-0013-8. eCollection 2016.
5
China's Health Reform Update.中国医改新进展
Annu Rev Public Health. 2017 Mar 20;38:431-448. doi: 10.1146/annurev-publhealth-031816-044247. Epub 2017 Jan 11.
6
Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries.财富与心血管健康:一项关于高、中、低收入国家高血压知晓、治疗和控制方面与财富相关不平等的横断面研究。
Int J Equity Health. 2016 Dec 8;15(1):199. doi: 10.1186/s12939-016-0478-6.
7
Adherence to Antihypertensive Therapy.抗高血压治疗的依从性
Med Clin North Am. 2017 Jan;101(1):229-245. doi: 10.1016/j.mcna.2016.08.005.
8
Health Insurance Coverage and Hypertension Control in China: Results from the China Health and Nutrition Survey.中国的医疗保险覆盖范围与高血压控制:来自中国健康与营养调查的结果
PLoS One. 2016 Mar 22;11(3):e0152091. doi: 10.1371/journal.pone.0152091. eCollection 2016.
9
Community health centers and primary care access and quality for chronically-ill patients - a case-comparison study of urban Guangdong Province, China.社区卫生中心与慢性病患者的初级医疗服务可及性及质量——中国广东省城市地区的病例对照研究
Int J Equity Health. 2015 Nov 30;14:90. doi: 10.1186/s12939-015-0222-7.
10
Consolidating the social health insurance schemes in China: towards an equitable and efficient health system.整合中国的社会医疗保险计划:迈向公平高效的卫生体系。
Lancet. 2015 Oct 10;386(10002):1484-92. doi: 10.1016/S0140-6736(15)00342-6.